The anti-cancer drug candidate CBL0137 induced necroptosis via forming left-handed Z-DNA and its binding protein ZBP1 in liver cells
- 22 November 2023
- journal article
- research article
- Published by Elsevier in Toxicology and Applied Pharmacology
- Vol. 482, 116765
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (21836005, 21976199, 92043301)
This publication has 47 references indexed in Scilit:
- DAI/ZBP1/DLM-1 Complexes with RIP3 to Mediate Virus-Induced Programmed Necrosis that Is Targeted by Murine Cytomegalovirus vIRACell Host & Microbe, 2012
- Curaxins: Anticancer Compounds That Simultaneously Suppress NF-κB and Activate p53 by Targeting FACTScience Translational Medicine, 2011
- Intrinsic Z-DNA Is Stabilized by the Conformational Selection Mechanism of Z-DNA-Binding ProteinsJournal of the American Chemical Society, 2010
- Molecular mechanisms of necroptosis: an ordered cellular explosionNature Reviews Molecular Cell Biology, 2010
- NMR Spectroscopic Elucidation of the B−Z Transition of a DNA Double Helix Induced by the Zα Domain of Human ADAR1Journal of the American Chemical Society, 2009
- Discovery of the Role of Non-B DNA Structures in Mutagenesis and Human Genomic DisordersJournal of Biological Chemistry, 2009
- The crystal structure of the second Z-DNA binding domain of human DAI (ZBP1) in complex with Z-DNA reveals an unusual binding mode to Z-DNAProceedings of the National Academy of Sciences, 2008
- Role of DNA dynamics in Alzheimer's diseaseBrain Research Reviews, 2008
- A Left-Handed RNA Double Helix Bound by the Zα Domain of the RNA-Editing Enzyme ADAR1Structure, 2007
- Apoptosis Genes and Resistance to Cancer Therapy: What Does the Experimental and Clinical Data Tell Us?Cancer Biology & Therapy, 2003